BMO Capital Downgrades Pfizer (PFE) to Market Perform
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.54 -0.16%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Join SI Premium – FREE
BMO Capital downgraded Pfizer (NYSE: PFE) from Outperform to Market Perform with a price target of $33.00 (from $40.00).
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $31.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Delivery Hero SE (DHER:GR) (DLVHF) to Hold
- ICICI Securities Downgrades Dr Lal PathLabs Ltd (DLPL:IN) to Hold (3)
- Summit Therapeutics plc (SMMT) PT Lowered to $38 at Stifel, But 'Fundamental Conviction Intact'
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
